Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
July 18 2022 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated
to the development of innovative therapeutics for neurotology,
today announced it will report financial results for the second
quarter 2022 and provide a corporate update at 4:30 p.m. ET on July
25, 2022.
A live webcast of the call will be available online in the
investor relations section of Otonomy’s website at www.otonomy.com
and will be archived there for 30 days. To access the live call by
phone, please go to this link (registration link), and you will be
provided with dial-in details. To avoid delays, we encourage
participants to dial into the conference call fifteen minutes ahead
of the scheduled start time.
About Otonomy Otonomy is a
biopharmaceutical company dedicated to the development of
innovative therapeutics for neurotology. The company pioneered the
application of drug delivery technology to the ear in order to
develop products that achieve sustained drug exposure from a single
local administration. This approach is covered by a broad patent
estate and is being utilized to develop a pipeline of products
addressing important unmet medical needs with a focus on hearing
loss and tinnitus. For additional information, please visit
www.otonomy.com.
Contacts:
Media Inquiries:Spectrum ScienceLauren BentonSenior Account
Executive212.899.9731lbenton@spectrumscience.com
Investor Inquiries:ICR WestwickeRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Nov 2023 to Nov 2024